speb/financial-data huggingface dataset:
CLH income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1942759.00
CLH income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLH income_statement (annual, 2025-12-31) — Tax Provision: 136993000.00
CLH income_statement (quarterly, 2025-12-31) — Tax Provision: 33352000.00
CLH income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.26
CLH income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.28
CLH balance_sheet (annual, 2025-12-31) — Total Assets: 7624056000.00
CLH balance_sheet (quarterly, 2025-12-31) — Total Assets: 7624056000.00
CLH balance_sheet (annual, 2025-12-31) — Total Capitalization: 5509223000.00
CLH balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 5509223000.00
CLH balance_sheet (annual, 2025-12-31) — Total Debt: 3035697000.00
CLH balance_sheet (quarterly, 2025-12-31) — Total Debt: 3035697000.00
CLH balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2745660000.00
CLH balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2745660000.00
CLH income_statement (annual, 2025-12-31) — Total Expenses: 5357465000.00
CLH income_statement (quarterly, 2025-12-31) — Total Expenses: 1341250000.00
CLH balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 4878396000.00
CLH balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4878396000.00
CLH balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 4976813000.00
CLH balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4976813000.00
CLH balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3741549000.00
CLH balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3741549000.00
CLH income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 673372000.00
CLH income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 158446000.00
CLH balance_sheet (annual, 2025-12-31) — Total Tax Payable: 42082000.00
CLH balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 42082000.00
CLH income_statement (annual, 2025-12-31) — Total Unusual Items: -7501000.00
CLH income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -7501000.00
CLH balance_sheet (annual, 2025-12-31) — Working Capital: 1510396000.00
CLH balance_sheet (quarterly, 2025-12-31) — Working Capital: 1510396000.00
CLH income_statement (quarterly, 2026-03-31) — +Operating Expense: 326482000.00
CLH income_statement (quarterly, 2026-03-31) — +Total Revenue: 1459537000.00
CLH balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 464173000.00
CLH balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1113163000.00
CLH balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3113971000.00
CLH balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 169172000.00
CLH balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -37645000.00
CLH income_statement (quarterly, 2026-03-31) — Amortization: 13674000.00
CLH cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 13674000.00
CLH cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 13674000.00
CLH income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 13674000.00
CLH income_statement (quarterly, 2026-03-31) — Basic Average Shares: 52821000.00
CLH income_statement (quarterly, 2026-03-31) — Basic EPS: 1.20
CLH cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 826315000.00
CLH balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 756361000.00
CLH cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -98602000.00
CLH balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 267866000.00
CLH balance_sheet (quarterly, 2026-03-31) — Capital Stock: 528000.00
CLH balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 547994000.00
CLH balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 669034000.00
CLH cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -58253000.00
CLH cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -222723000.00
CLH cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 6297000.00
CLH cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -40814000.00
CLH cash_flow (quarterly, 2026-03-31) — Change In Inventory: 7803000.00
CLH cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 7513000.00
CLH cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -54780000.00
CLH cash_flow (quarterly, 2026-03-31) — Change In Payable: -40814000.00
CLH cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -40814000.00
CLH cash_flow (quarterly, 2026-03-31) — Change In Receivables: -104781000.00
CLH cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -185059000.00
CLH cash_flow (quarterly, 2026-03-31) — Changes In Cash: -274679000.00
CLH balance_sheet (quarterly, 2026-03-31) — Common Stock: 528000.00
CLH balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2775503000.00
CLH cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -25000000.00
CLH balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 119067000.00
CLH income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1014120000.00
CLH balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 247222000.00
CLH balance_sheet (quarterly, 2026-03-31) — Current Assets: 2443132000.00
CLH balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 78069000.00
CLH balance_sheet (quarterly, 2026-03-31) — Current Debt: 12600000.00
CLH balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 90669000.00
CLH balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 82858000.00
CLH balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 82858000.00
CLH balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1042959000.00
CLH balance_sheet (quarterly, 2026-03-31) — Current Provisions: 21129000.00
CLH cash_flow (quarterly, 2026-03-31) — Depreciation: 102125000.00
CLH cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 115799000.00
CLH income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 115799000.00
CLH cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 115799000.00
CLH income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 115799000.00
CLH income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 102125000.00
CLH income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 52992000.00
CLH income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.19
CLH income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 63201000.00
CLH income_statement (quarterly, 2026-03-31) — EBIT: 124617000.00
CLH income_statement (quarterly, 2026-03-31) — EBITDA: 240416000.00
CLH cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -3642000.00
CLH cash_flow (quarterly, 2026-03-31) — End Cash Position: 547994000.00
CLH cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -58253000.00
CLH balance_sheet (quarterly, 2026-03-31) — Finished Goods: 112423000.00
CLH cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -92305000.00
CLH balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -213249000.00
CLH balance_sheet (quarterly, 2026-03-31) — Goodwill: 1555062000.00
CLH balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2234143000.00
CLH balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1150808000.00
CLH balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5939378000.00
CLH income_statement (quarterly, 2026-03-31) — Gross Profit: 445417000.00
CLH cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 7916000.00
CLH income_statement (quarterly, 2026-03-31) — Interest Expense: 40267000.00
CLH income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 40267000.00
CLH income_statement (quarterly, 2026-03-31) — Interest Income: 6413000.00
CLH income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 6413000.00
CLH cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 38435000.00
CLH balance_sheet (quarterly, 2026-03-31) — Interest Payable: 29655000.00
CLH balance_sheet (quarterly, 2026-03-31) — Inventory: 363935000.00
CLH balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5549520000.00
CLH cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -222723000.00
CLH balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 196798000.00
CLH balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 189797000.00
CLH balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2761417000.00
CLH balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2951214000.00
CLH cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -15751000.00
CLH balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 123334000.00
CLH balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 1601305000.00
CLH cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -131820000.00
CLH cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -25000000.00
CLH balance_sheet (quarterly, 2026-03-31) — Net Debt: 2226023000.00
CLH income_statement (quarterly, 2026-03-31) — Net Income: 63201000.00
CLH income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 63201000.00
CLH income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 63201000.00
CLH income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 63201000.00
CLH income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 63201000.00
CLH cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 63201000.00
CLH income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 63201000.00
CLH cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -159000.00
CLH income_statement (quarterly, 2026-03-31) — Net Interest Income: -33854000.00
CLH cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 6177000.00
CLH cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -15751000.00
CLH cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -15751000.00
CLH income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -33854000.00
CLH cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -17502000.00
CLH balance_sheet (quarterly, 2026-03-31) — Net PPE: 2825407000.00
CLH cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -96921000.00
CLH balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 541360000.00
CLH balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 384297000.00
CLH balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 384297000.00
CLH income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 240416000.00
CLH income_statement (quarterly, 2026-03-31) — Normalized Income: 63201000.00
CLH cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 6297000.00
CLH income_statement (quarterly, 2026-03-31) — Operating Income: 118935000.00
CLH income_statement (quarterly, 2026-03-31) — Operating Revenue: 1459537000.00
CLH balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 52833291.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 104759000.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 12600000.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -213249000.00
CLH income_statement (quarterly, 2026-03-31) — Other Income Expense: -731000.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 679081000.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Inventories: 31457000.00
CLH cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -141000.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 49884000.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 275259000.00
CLH income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -731000.00
CLH income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 3542000.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Properties: 3265847000.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Receivables: 192241000.00
CLH balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 121040000.00
CLH balance_sheet (quarterly, 2026-03-31) — Payables: 513786000.00
CLH balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 761008000.00
CLH balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 87295000.00
CLH income_statement (quarterly, 2026-03-31) — Pretax Income: 84350000.00
CLH balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CLH cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 2919000.00
CLH cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -131820000.00
CLH cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -159000.00
CLH cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -16142000.00
CLH cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -98443000.00
CLH balance_sheet (quarterly, 2026-03-31) — Raw Materials: 220055000.00
CLH balance_sheet (quarterly, 2026-03-31) — Receivables: 1305404000.00
CLH income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1014120000.00
CLH income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 115799000.00
CLH cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -15751000.00
CLH cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -25000000.00
CLH balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2819052000.00
CLH cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 22319000.00
CLH cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 1522000.00
CLH income_statement (quarterly, 2026-03-31) — Selling General And Administration: 207141000.00
CLH balance_sheet (quarterly, 2026-03-31) — Share Issued: 52833291.00
CLH cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 9578000.00
CLH balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2775503000.00
CLH balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 541360000.00
CLH income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CLH income_statement (quarterly, 2026-03-31) — Tax Provision: 21149000.00
CLH income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
CLH balance_sheet (quarterly, 2026-03-31) — Total Assets: 7552566000.00
CLH balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5536920000.00
CLH balance_sheet (quarterly, 2026-03-31) — Total Debt: 3041883000.00
CLH balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2775503000.00
CLH income_statement (quarterly, 2026-03-31) — Total Expenses: 1340602000.00
CLH balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4777063000.00
CLH balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5109434000.00
CLH balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3734104000.00
CLH income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 118935000.00
CLH balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 49613000.00
CLH balance_sheet (quarterly, 2026-03-31) — Working Capital: 1400173000.00
CLI.L balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -2400000.00
CLI.L balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 1700000.00
CLI.L income_statement (annual, 2021-12-31) — Basic Average Shares: 407395760.00
CLI.L income_statement (annual, 2021-12-31) — Basic EPS: 0.29
CLI.L cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
CLI.L income_statement (annual, 2021-12-31) — Diluted Average Shares: 407395760.00
CLI.L income_statement (annual, 2021-12-31) — Diluted EPS: 0.29
CLI.L cash_flow (annual, 2021-12-31) — Dividends Received Cfi: 200000.00
CLI.L balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 1700000.00
CLI.L balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 4900000.00
CLI.L balance_sheet (annual, 2021-12-31) — Land And Improvements: 3200000.00
CLI.L cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 500000.00
CLI.L cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
CLI.L cash_flow (annual, 2021-12-31) — Net Investment Properties Purchase And Sale: -127600000.00
CLI.L cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -1300000.00
CLI.L balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 2600000.00
CLI.L income_statement (annual, 2021-12-31) — Other Operating Expenses: 14400000.00
CLI.L cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
CLI.L cash_flow (annual, 2021-12-31) — Purchase Of Investment Properties: -164600000.00
CLI.L cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
CLI.L income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 1200000.00
CLI.L cash_flow (annual, 2021-12-31) — Sale Of Business: 500000.00
CLI.L cash_flow (annual, 2021-12-31) — Sale Of Investment Properties: 37000000.00
CLI.L income_statement (annual, 2022-12-31) — +Operating Expense: 15700000.00
CLI.L income_statement (annual, 2022-12-31) — +Total Revenue: 139700000.00
CLI.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 4600000.00
CLI.L balance_sheet (annual, 2022-12-31) — Accounts Receivable: 5300000.00
CLI.L balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 105800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -2800000.00
CLI.L cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 0.00
CLI.L balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 20300000.00
CLI.L income_statement (annual, 2022-12-31) — Basic Average Shares: 404410051.00
CLI.L income_statement (annual, 2022-12-31) — Basic EPS: -0.20
CLI.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 167400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 26700000.00
CLI.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -58400000.00
CLI.L cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -57200000.00
CLI.L balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3600000.00
CLI.L balance_sheet (annual, 2022-12-31) — Capital Stock: 11000000.00
CLI.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 87800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 87800000.00
CLI.L cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -32400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Cash Financial: 87800000.00
CLI.L cash_flow (annual, 2022-12-31) — Change In Payable: -700000.00
CLI.L cash_flow (annual, 2022-12-31) — Change In Receivables: 2300000.00
CLI.L cash_flow (annual, 2022-12-31) — Change In Working Capital: 1600000.00
CLI.L cash_flow (annual, 2022-12-31) — Changes In Cash: -52900000.00
CLI.L balance_sheet (annual, 2022-12-31) — Common Stock: 11000000.00
CLI.L cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -32400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1220800000.00
CLI.L cash_flow (annual, 2022-12-31) — Common Stock Payments: -25800000.00
CLI.L income_statement (annual, 2022-12-31) — Cost Of Revenue: 48100000.00
CLI.L balance_sheet (annual, 2022-12-31) — Current Assets: 150000000.00
CLI.L balance_sheet (annual, 2022-12-31) — Current Debt: 173400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 173400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Current Liabilities: 234000000.00
CLI.L cash_flow (annual, 2022-12-31) — Depreciation: 600000.00
CLI.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 600000.00
CLI.L balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
CLI.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 404410051.00
CLI.L income_statement (annual, 2022-12-31) — Diluted EPS: -0.20
CLI.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -81900000.00
CLI.L cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 0.00
CLI.L income_statement (annual, 2022-12-31) — EBIT: -57000000.00
CLI.L income_statement (annual, 2022-12-31) — EBITDA: -56400000.00
CLI.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -600000.00
CLI.L cash_flow (annual, 2022-12-31) — End Cash Position: 113900000.00
CLI.L balance_sheet (annual, 2022-12-31) — Financial Assets: 8500000.00
CLI.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: -14600000.00
CLI.L cash_flow (annual, 2022-12-31) — Free Cash Flow: -15400000.00
CLI.L cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 139800000.00
CLI.L income_statement (annual, 2022-12-31) — General And Administrative Expense: 15700000.00
CLI.L balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 2800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 8100000.00
CLI.L balance_sheet (annual, 2022-12-31) — Gross PPE: 41000000.00
CLI.L income_statement (annual, 2022-12-31) — Gross Profit: 91600000.00
CLI.L balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 0.00
CLI.L income_statement (annual, 2022-12-31) — Interest Expense: 25000000.00
CLI.L income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 25000000.00
CLI.L income_statement (annual, 2022-12-31) — Interest Income: 1300000.00
CLI.L income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1300000.00
CLI.L cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -24200000.00
CLI.L cash_flow (annual, 2022-12-31) — Interest Received Cfo: 1300000.00
CLI.L balance_sheet (annual, 2022-12-31) — Invested Capital: 2326700000.00
CLI.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: -81300000.00
CLI.L balance_sheet (annual, 2022-12-31) — Investment Properties: 2295000000.00
CLI.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 144100000.00
CLI.L balance_sheet (annual, 2022-12-31) — Land And Improvements: 0.00
CLI.L balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3600000.00
CLI.L balance_sheet (annual, 2022-12-31) — Long Term Debt: 932500000.00
CLI.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 936100000.00
CLI.L cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 144100000.00
CLI.L cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -99400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 2700000.00
CLI.L balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 3500000.00
CLI.L cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CLI.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -25800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Net Debt: 1018100000.00
CLI.L income_statement (annual, 2022-12-31) — Net Income: -81900000.00
CLI.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -81900000.00
CLI.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -81900000.00
CLI.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -81900000.00
CLI.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -81900000.00
CLI.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -63900000.00
CLI.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -81900000.00
CLI.L cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -800000.00
CLI.L income_statement (annual, 2022-12-31) — Net Interest Income: -25500000.00
CLI.L cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: -27200000.00
CLI.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 44700000.00
CLI.L cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 44700000.00
CLI.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -25500000.00
CLI.L cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -3400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Net PPE: 39600000.00
CLI.L cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1218000000.00
CLI.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 2800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 110500000.00
CLI.L income_statement (annual, 2022-12-31) — Normalized EBITDA: -61400000.00
CLI.L income_statement (annual, 2022-12-31) — Normalized Income: -84700000.00
CLI.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: 43000000.00
CLI.L income_statement (annual, 2022-12-31) — Operating Income: 75900000.00
CLI.L income_statement (annual, 2022-12-31) — Operating Revenue: 139700000.00
CLI.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 397210866.00
CLI.L balance_sheet (annual, 2022-12-31) — Other Equity Interest: 1900000.00
CLI.L cash_flow (annual, 2022-12-31) — Other Non Cash Items: -7800000.00
CLI.L income_statement (annual, 2022-12-31) — Other Operating Expenses: 16200000.00
CLI.L balance_sheet (annual, 2022-12-31) — Other Payable: 4200000.00
CLI.L balance_sheet (annual, 2022-12-31) — Other Properties: 10800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Other Receivables: 7800000.00
CLI.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLI.L balance_sheet (annual, 2022-12-31) — Payables: 12900000.00
CLI.L balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2700000.00
CLI.L income_statement (annual, 2022-12-31) — Pretax Income: -82000000.00
CLI.L balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLI.L cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -800000.00
CLI.L cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -83400000.00
CLI.L cash_flow (annual, 2022-12-31) — Purchase Of PPE: -400000.00
CLI.L income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 48100000.00
CLI.L income_statement (annual, 2022-12-31) — Reconciled Depreciation: 600000.00
CLI.L cash_flow (annual, 2022-12-31) — Repayment Of Debt: -99400000.00
CLI.L cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -25800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Restricted Cash: 26100000.00
CLI.L balance_sheet (annual, 2022-12-31) — Retained Earnings: 1011300000.00
CLI.L cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CLI.L cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 56200000.00
CLI.L cash_flow (annual, 2022-12-31) — Sale Of PPE: 56200000.00
CLI.L income_statement (annual, 2022-12-31) — Selling General And Administration: 15700000.00
CLI.L balance_sheet (annual, 2022-12-31) — Share Issued: 438777780.00
CLI.L income_statement (annual, 2022-12-31) — Special Income Charges: -1100000.00
CLI.L cash_flow (annual, 2022-12-31) — Stock Based Compensation: 200000.00
CLI.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1220800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1218000000.00
CLI.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLI.L income_statement (annual, 2022-12-31) — Tax Provision: -100000.00
CLI.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CLI.L cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -4600000.00
CLI.L balance_sheet (annual, 2022-12-31) — Total Assets: 2501400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 2153300000.00
CLI.L balance_sheet (annual, 2022-12-31) — Total Debt: 1109500000.00
CLI.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1220800000.00
CLI.L income_statement (annual, 2022-12-31) — Total Expenses: 63800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1280600000.00
CLI.L balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 2351400000.00
CLI.L balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1046600000.00
CLI.L income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -63900000.00
CLI.L income_statement (annual, 2022-12-31) — Total Other Finance Cost: 1800000.00
CLI.L balance_sheet (annual, 2022-12-31) — Total Tax Payable: 4100000.00
CLI.L income_statement (annual, 2022-12-31) — Total Unusual Items: 5000000.00
CLI.L income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 3900000.00
CLI.L balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 41566914.00
CLI.L balance_sheet (annual, 2022-12-31) — Working Capital: -84000000.00
CLI.L income_statement (annual, 2023-12-31) — +Operating Expense: 18200000.00
CLI.L income_statement (annual, 2023-12-31) — +Total Revenue: 148700000.00
CLI.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 4100000.00
CLI.L balance_sheet (annual, 2023-12-31) — Accounts Receivable: 8800000.00
CLI.L balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1800000.00
CLI.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 105800000.00
CLI.L balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -1900000.00
CLI.L cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 200000.00
CLI.L balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 172700000.00
CLI.L income_statement (annual, 2023-12-31) — Basic Average Shares: 397330507.00
CLI.L income_statement (annual, 2023-12-31) — Basic EPS: -0.63
CLI.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 113900000.00
CLI.L balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 30200000.00
CLI.L cash_flow (annual, 2023-12-31) — Capital Expenditure: -47500000.00
CLI.L cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -46400000.00
CLI.L balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 3500000.00
CLI.L balance_sheet (annual, 2023-12-31) — Capital Stock: 11000000.00
CLI.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 33800000.00
CLI.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 33800000.00
CLI.L cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -31600000.00
CLI.L balance_sheet (annual, 2023-12-31) — Cash Financial: 33800000.00
CLI.L cash_flow (annual, 2023-12-31) — Change In Payable: 4700000.00
CLI.L cash_flow (annual, 2023-12-31) — Change In Receivables: -900000.00
CLI.L cash_flow (annual, 2023-12-31) — Change In Working Capital: 3800000.00
CLI.L cash_flow (annual, 2023-12-31) — Changes In Cash: -42600000.00
CLI.L balance_sheet (annual, 2023-12-31) — Common Stock: 11000000.00
CLI.L cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -31600000.00
CLI.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: 929200000.00
CLI.L cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
CLI.L income_statement (annual, 2023-12-31) — Cost Of Revenue: 51300000.00
CLI.L balance_sheet (annual, 2023-12-31) — Current Assets: 260700000.00
CLI.L balance_sheet (annual, 2023-12-31) — Current Debt: 193900000.00
CLI.L balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 193900000.00
CLI.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 262800000.00
CLI.L cash_flow (annual, 2023-12-31) — Depreciation: 600000.00
CLI.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 800000.00
CLI.L balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 0.00
CLI.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 397330507.00
CLI.L income_statement (annual, 2023-12-31) — Diluted EPS: -0.63
CLI.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -249800000.00
CLI.L income_statement (annual, 2023-12-31) — EBIT: -227900000.00
CLI.L income_statement (annual, 2023-12-31) — EBITDA: -227100000.00
CLI.L cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -700000.00
CLI.L cash_flow (annual, 2023-12-31) — End Cash Position: 70600000.00
CLI.L balance_sheet (annual, 2023-12-31) — Financial Assets: 3600000.00
CLI.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: -56200000.00
CLI.L cash_flow (annual, 2023-12-31) — Free Cash Flow: -1600000.00
CLI.L cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 302600000.00
CLI.L income_statement (annual, 2023-12-31) — General And Administrative Expense: 18200000.00
CLI.L balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2900000.00
CLI.L balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 10700000.00
CLI.L balance_sheet (annual, 2023-12-31) — Gross PPE: 43600000.00
CLI.L income_statement (annual, 2023-12-31) — Gross Profit: 97400000.00
CLI.L balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 700000.00
CLI.L income_statement (annual, 2023-12-31) — Interest Expense: 35500000.00
CLI.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 35500000.00
CLI.L income_statement (annual, 2023-12-31) — Interest Income: 1600000.00
CLI.L income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1600000.00
CLI.L cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -35100000.00
CLI.L cash_flow (annual, 2023-12-31) — Interest Received Cfo: 1600000.00
CLI.L balance_sheet (annual, 2023-12-31) — Invested Capital: 1999800000.00
CLI.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: -32300000.00
CLI.L balance_sheet (annual, 2023-12-31) — Investment Properties: 1850500000.00
CLI.L cash_flow (annual, 2023-12-31) — Issuance Of Debt: 72500000.00
CLI.L balance_sheet (annual, 2023-12-31) — Land And Improvements: 0.00
CLI.L balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 3500000.00
CLI.L balance_sheet (annual, 2023-12-31) — Long Term Debt: 876700000.00
CLI.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 880200000.00
CLI.L cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 72500000.00
CLI.L cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -96000000.00
CLI.L balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 1400000.00
CLI.L balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 3900000.00
CLI.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CLI.L balance_sheet (annual, 2023-12-31) — Net Debt: 1036800000.00
CLI.L income_statement (annual, 2023-12-31) — Net Income: -249800000.00
CLI.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -249800000.00
CLI.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -249800000.00
CLI.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -249800000.00
CLI.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -249800000.00
CLI.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -223400000.00
CLI.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -249800000.00
CLI.L cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -300000.00
CLI.L income_statement (annual, 2023-12-31) — Net Interest Income: -35500000.00
CLI.L cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: 17000000.00
CLI.L cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -23500000.00
CLI.L cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -23500000.00
CLI.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -35500000.00
CLI.L cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -1800000.00
CLI.L balance_sheet (annual, 2023-12-31) — Net PPE: 41800000.00
CLI.L cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -800000.00
CLI.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 926300000.00
CLI.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 0.00
CLI.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 88700000.00
CLI.L income_statement (annual, 2023-12-31) — Normalized EBITDA: -221600000.00
CLI.L income_statement (annual, 2023-12-31) — Normalized Income: -244583978.74
CLI.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: 45900000.00
CLI.L income_statement (annual, 2023-12-31) — Operating Income: 79200000.00
CLI.L income_statement (annual, 2023-12-31) — Operating Revenue: 148700000.00
CLI.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 397410268.00
CLI.L balance_sheet (annual, 2023-12-31) — Other Equity Interest: 2400000.00
CLI.L cash_flow (annual, 2023-12-31) — Other Non Cash Items: -1100000.00
CLI.L balance_sheet (annual, 2023-12-31) — Other Payable: 5700000.00
CLI.L balance_sheet (annual, 2023-12-31) — Other Properties: 9500000.00
CLI.L balance_sheet (annual, 2023-12-31) — Other Receivables: 6500000.00
CLI.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLI.L balance_sheet (annual, 2023-12-31) — Payables: 12300000.00
CLI.L balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1400000.00
CLI.L income_statement (annual, 2023-12-31) — Pretax Income: -263400000.00
CLI.L balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLI.L cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -300000.00
CLI.L cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: 0.00
CLI.L cash_flow (annual, 2023-12-31) — Purchase Of PPE: -800000.00
CLI.L income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 51300000.00
CLI.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 800000.00
CLI.L cash_flow (annual, 2023-12-31) — Repayment Of Debt: -96000000.00
CLI.L cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
CLI.L balance_sheet (annual, 2023-12-31) — Restricted Cash: 36800000.00
CLI.L balance_sheet (annual, 2023-12-31) — Retained Earnings: 728400000.00
CLI.L cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 17000000.00
CLI.L cash_flow (annual, 2023-12-31) — Sale Of PPE: 17000000.00
CLI.L income_statement (annual, 2023-12-31) — Selling General And Administration: 18200000.00
CLI.L balance_sheet (annual, 2023-12-31) — Share Issued: 438777780.00
CLI.L income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CLI.L cash_flow (annual, 2023-12-31) — Stock Based Compensation: 500000.00
CLI.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: 929200000.00
CLI.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: 926300000.00
CLI.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -283978.74
CLI.L income_statement (annual, 2023-12-31) — Tax Provision: -13600000.00
CLI.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.05
CLI.L cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -3800000.00
CLI.L balance_sheet (annual, 2023-12-31) — Total Assets: 2160900000.00
CLI.L balance_sheet (annual, 2023-12-31) — Total Capitalization: 1805900000.00
CLI.L balance_sheet (annual, 2023-12-31) — Total Debt: 1074100000.00
CLI.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 929200000.00
CLI.L income_statement (annual, 2023-12-31) — Total Expenses: 69500000.00
CLI.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1231700000.00
CLI.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1900200000.00
CLI.L balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 968900000.00
CLI.L income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -223400000.00
CLI.L income_statement (annual, 2023-12-31) — Total Other Finance Cost: 1600000.00
CLI.L balance_sheet (annual, 2023-12-31) — Total Tax Payable: 2500000.00
CLI.L income_statement (annual, 2023-12-31) — Total Unusual Items: -5500000.00
CLI.L income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -5500000.00
CLI.L balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 41367512.00
CLI.L balance_sheet (annual, 2023-12-31) — Working Capital: -2100000.00
CLI.L income_statement (annual, 2024-12-31) — +Operating Expense: 17700000.00
CLI.L income_statement (annual, 2024-12-31) — +Total Revenue: 151900000.00
CLI.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 5200000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 5200000.00
CLI.L balance_sheet (annual, 2024-12-31) — Accounts Receivable: 4200000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 4200000.00
CLI.L balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2200000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -2200000.00
CLI.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 105800000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 105800000.00
CLI.L balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1700000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1700000.00
CLI.L cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 400000.00
CLI.L balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 133000000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 133000000.00
CLI.L income_statement (annual, 2024-12-31) — Basic Average Shares: 397410268.00
CLI.L income_statement (annual, 2024-12-31) — Basic EPS: -0.24
CLI.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 70600000.00
CLI.L balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 31400000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 31400000.00
CLI.L cash_flow (annual, 2024-12-31) — Capital Expenditure: -22700000.00
CLI.L cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -22300000.00
CLI.L balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3300000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 3300000.00
CLI.L balance_sheet (annual, 2024-12-31) — Capital Stock: 11000000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 11000000.00
CLI.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 9000000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 9000000.00
CLI.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 9000000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 9000000.00
CLI.L cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -31600000.00
CLI.L balance_sheet (annual, 2024-12-31) — Cash Financial: 9000000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Cash Financial: 9000000.00
CLI.L cash_flow (annual, 2024-12-31) — Change In Payable: -700000.00
CLI.L cash_flow (annual, 2024-12-31) — Change In Receivables: 2500000.00
CLI.L cash_flow (annual, 2024-12-31) — Change In Working Capital: 1800000.00
CLI.L cash_flow (annual, 2024-12-31) — Changes In Cash: -9200000.00
CLI.L balance_sheet (annual, 2024-12-31) — Common Stock: 11000000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 11000000.00
CLI.L cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -31600000.00
CLI.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: 784200000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 784200000.00
CLI.L income_statement (annual, 2024-12-31) — Cost Of Revenue: 56000000.00
CLI.L balance_sheet (annual, 2024-12-31) — Current Assets: 208800000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Current Assets: 208800000.00
CLI.L balance_sheet (annual, 2024-12-31) — Current Debt: 372400000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Current Debt: 372400000.00
CLI.L balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 372400000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 372400000.00
CLI.L balance_sheet (annual, 2024-12-31) — Current Liabilities: 439000000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 439000000.00
CLI.L cash_flow (annual, 2024-12-31) — Depreciation: 600000.00
CLI.L cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1000000.00
CLI.L balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 400000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 400000.00
CLI.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 397410268.00
CLI.L income_statement (annual, 2024-12-31) — Diluted EPS: -0.24
CLI.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -93600000.00
CLI.L income_statement (annual, 2024-12-31) — EBIT: -56800000.00
CLI.L income_statement (annual, 2024-12-31) — EBITDA: -55800000.00
CLI.L cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -900000.00
CLI.L cash_flow (annual, 2024-12-31) — End Cash Position: 60500000.00
CLI.L balance_sheet (annual, 2024-12-31) — Financial Assets: 700000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Financial Assets: 700000.00
CLI.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: -79800000.00
CLI.L cash_flow (annual, 2024-12-31) — Free Cash Flow: 6800000.00
CLI.L cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 130700000.00
CLI.L income_statement (annual, 2024-12-31) — General And Administrative Expense: 17700000.00
CLI.L balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 2700000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 2700000.00
CLI.L balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 4200000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 4200000.00
CLI.L balance_sheet (annual, 2024-12-31) — Gross PPE: 44700000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Gross PPE: 44700000.00
CLI.L income_statement (annual, 2024-12-31) — Gross Profit: 95900000.00
CLI.L balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 1100000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 1100000.00
CLI.L income_statement (annual, 2024-12-31) — Interest Expense: 40600000.00
CLI.L income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 40600000.00
CLI.L income_statement (annual, 2024-12-31) — Interest Income: 1400000.00
CLI.L income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1400000.00
CLI.L cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -40600000.00
CLI.L cash_flow (annual, 2024-12-31) — Interest Received Cfo: 1400000.00
CLI.L balance_sheet (annual, 2024-12-31) — Invested Capital: 1783400000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: 1783400000.00
CLI.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: 41100000.00
CLI.L balance_sheet (annual, 2024-12-31) — Investment Properties: 1676500000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Investment Properties: 1676500000.00
CLI.L cash_flow (annual, 2024-12-31) — Issuance Of Debt: 8800000.00
CLI.L balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 3300000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 3300000.00
CLI.L balance_sheet (annual, 2024-12-31) — Long Term Debt: 626800000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 626800000.00
CLI.L balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 630100000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 630100000.00
CLI.L cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 8800000.00
CLI.L cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -55500000.00
CLI.L balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 600000.00
CLI.L balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 600000.00